Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLS | GRND |
|---|---|---|
| Price | $11.63 | $13.54 |
| Change today | ▼ 0.94% | ▲ 0.82% |
| Market cap | $2.35B | $2.35B |
| Return, 3 months | -13.9% | -13.1% |
| Return, year to date | +208.5% | 0.0% |
| Return, 1 year | +515.3% | -4.0% |
| P/E (TTM) | -52.9 | 27.1 |
| P/B | 17.1 | -199.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +32.5% |
| Net profit growth (YoY) | -45.5% | +6.6% |
| Gross margin | – | 74.9% |
| Operating margin | – | 29.8% |
| Net margin | – | 18.7% |
| Return on equity | – | 108.7% |
| Analyst target vs. price | +158.0% | +53.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 46 | 32 |
| 30-day volatility | 87.9% | 43.2% |
| Max drawdown, 1 year | -36.2% | -38.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
